|
1
|
Hale CM, Seabury RW, Steele JM, Darko W
and Miller CD: Are vancomycin trough concentrations of 15 to 20
mg/L associated with increased attainment of an AUC/MIC ≥ 400 in
patients with presumed MRSA infection? J Pharm Pract. 12:12–13.
2016.
|
|
2
|
Aktaş Z, Satana D, Kayacan C, Can B,
Gönüllü N and Küçükbasmacı O: Antibiotic susceptibility rates and
beta-lactam resistance mechanisms of Pseudomonas aeruginosa
strains. Mikrobiyol Bul. 46:386–397. 2012.(In Turkish). PubMed/NCBI
|
|
3
|
Li H, Luo YF, Williams BJ, Blackwell TS
and Xie CM: Structure and function of OprD protein in Pseudomonas
aeruginosa: from antibiotic resistance to novel therapies. Int J
Med Microbiol. 302:63–68. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harrison EM, Ba X, Blane B, Ellington MJ,
Loeffler A, Hill RL, Holmes MA and Peacock SJ: PBP2a substitutions
linked to ceftaroline resistance in MRSA isolates from the UK. J
Antimicrob Chemother. 71:268–269. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ostojić M and Hukić M: Genotypic and
phenotypic characteristics of methicillin-resistant Staphylococcus
aureus (MRSA) strains, isolated on three different geography
locations. Bosn J Basic Med Sci. 15:48–56. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang R, Zheng T, Cai X, Yu Y, Yu C, Guo L,
Huang S, Zhu W, Zhu R, Yan Q, et al: Genome-wide analyses of
amphioxus microRNAs reveal an immune regulation via miR-92d
targeting C3. J Immunol. 190:1491–1500. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Magiorakos AP, Srinivasan A, Carey RB,
Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter
G, Olsson-Liljequist B, et al: Multidrug-resistant, extensively
drug-resistant and pandrug-resistant bacteria: an international
expert proposal for interim standard definitions for acquired
resistance. Clin Microbiol Infect. 18:268–281. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Datta J, Islam M, Dutta S, Roy S, Pan Q
and Teknos TN: Suberoylanilide hydroxamic acid inhibits growth of
head and neck cancer cell lines by reactivation of tumor suppressor
microRNAs. Oral Oncol. 56:32–39. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li MM, Addepalli B, Tu MJ, Chen QX, Wang
WP, Limbach PA, LaSalle JM, Zeng S, Huang M and Yu AM: Chimeric
microRNA-1291 biosynthesized efficiently in Escherichia coli is
effective to reduce target gene expression in human carcinoma cells
and improve chemosensitivity. Drug Metab Dispos. 43:1129–1136.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li MM, Wang WP, Wu WJ, Huang M and Yu AM:
Rapid production of novel pre-microRNA agent hsa-mir-27b in
Escherichia coli using recombinant RNA technology for functional
studies in mammalian cells. Drug Metab Dispos. 42:1791–1795. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin W, Ibeagha-Awemu EM, Liang G, Beaudoin
F, Zhao X and Guan L: Transcriptome microRNA profiling of bovine
mammary epithelial cells challenged with Escherichia coli or
Staphylococcus aureus bacteria reveals pathogen directed microRNA
expression profiles. BMC Genomics. 15:1812014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun J, Aswath K, Schroeder SG, Lippolis
JD, Reinhardt TA and Sonstegard TS: MicroRNA expression profiles of
bovine milk exosomes in response to Staphylococcus aureus
infection. BMC Genomics. 16:8062015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou Y, Zhao R, Ma B, Gao H, Xue X, Qu D,
Li M, Meng J, Luo X and Hou Z: Oligomerization of RNAIII-inhibiting
peptide inhibits adherence and biofilm formation of
methicillin-resistant Staphylococcus aureus in vitro and in vivo.
Microb Drug Resist. 22:193–201. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gupta RK, Luong TT and Lee CY: RNAIII of
the Staphylococcus aureus agr system activates global regulator
MgrA by stabilizing mRNA. Proc Natl Acad Sci USA. 112:14036–14041.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma B, Zhou Y, Li M, Yu Q, Xue X, Li Z, Da
F, Hou Z and Luo X: RIP-V improves murine survival in a sepsis
model by down-regulating RNAIII expression and α-hemolysin release
of methicillin-resistant Staphylococcus aureus. Pharmazie.
70:81–87. 2015.PubMed/NCBI
|
|
16
|
Zhang X, Zhu Q, Tian T, Zhao C, Zang J,
Xue T and Sun B: Identification of RNAIII-binding proteins in
Staphylococcus aureus using tethered RNAs and streptavidin aptamers
based pull-down assay. BMC Microbiol. 15:1022015. View Article : Google Scholar : PubMed/NCBI
|
